Literature DB >> 10881690

Phylogenetic analysis of H7 haemagglutinin subtype influenza A viruses.

J Banks1, E C Speidel, J W McCauley, D J Alexander.   

Abstract

A 945 nucleotide region (bases 76-1020) of the HA1 part of the HA gene was obtained for 31 influenza viruses of H7 subtype isolated primarily from Europe, Asia and Australia over the last 20 years. These were analysed phylogenetically and compared with sequences of the same region from 23 H7 subtype viruses available in Genbank. The overall results showed two geographically distinct lineages of North American and Eurasian viruses with major sublineages of Australian, historical European and equine viruses. Genetically related sublineages and clades within these major groups appeared to reflect geographical and temporal parameters rather than being defined by host avian species. Viruses of high and low virulence shared the same phylogenetic branches, supporting the theory that virulent viruses are not maintained as a separate entity in waterfowl.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10881690     DOI: 10.1007/s007050050695

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  34 in total

1.  Evaluation of diagnostic applications of monoclonal antibodies against avian influenza H7 viruses.

Authors:  Ming Yang; Alfonso Clavijo; Jill Graham; John Pasick; James Neufeld; Yohannes Berhane
Journal:  Clin Vaccine Immunol       Date:  2010-07-21

Review 2.  Epidemiology, ecology and gene pool of influenza A virus in Egypt: will Egypt be the epicentre of the next influenza pandemic?

Authors:  E M Abdelwhab; Ahmed S Abdel-Moneim
Journal:  Virulence       Date:  2015       Impact factor: 5.882

3.  A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys.

Authors:  Ji-Young Min; Leatrice Vogel; Yumiko Matsuoka; Bin Lu; David Swayne; Hong Jin; George Kemble; Kanta Subbarao
Journal:  J Virol       Date:  2010-09-01       Impact factor: 5.103

4.  Oseltamivir inhibits H7 influenza virus replication in mice inoculated by the ocular route.

Authors:  Jessica A Belser; Katrina Sleeman; Melissa B Pearce; Jacqueline M Katz; Larisa V Gubareva; Terrence M Tumpey
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

Review 5.  Human health implications of avian influenza viruses and paramyxoviruses.

Authors:  I Capua; D J Alexander
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-12-09       Impact factor: 3.267

6.  Zoonotic potential of highly pathogenic avian H7N3 influenza viruses from Pakistan.

Authors:  Uzma B Aamir; Khalid Naeem; Zaheer Ahmed; Caroline A Obert; John Franks; Scott Krauss; Patrick Seiler; Robert G Webster
Journal:  Virology       Date:  2009-06-16       Impact factor: 3.616

7.  A pilot study of the immune response to whole inactivated avian influenza H7N1 virus vaccine in mice.

Authors:  Arnt-Ove Hovden; Karl A Brokstad; Diane Major; John Wood; Lars R Haaheim; Rebecca J Cox
Journal:  Influenza Other Respir Viruses       Date:  2009-01       Impact factor: 4.380

Review 8.  Past, present, and possible future human infection with influenza virus A subtype H7.

Authors:  Jessica A Belser; Carolyn B Bridges; Jacqueline M Katz; Terrence M Tumpey
Journal:  Emerg Infect Dis       Date:  2009-06       Impact factor: 6.883

9.  An inactivated vaccine to control the current H9N2 low pathogenic avian influenza in Korea.

Authors:  Jun Gu Choi; Youn Jeong Lee; Yong Joo Kim; Eun Kyoung Lee; Ok Mi Jeong; Haan Woo Sung; Jae Hong Kim; Jun Hun Kwon
Journal:  J Vet Sci       Date:  2008-03       Impact factor: 1.672

10.  Susceptibility of Canada Geese (Branta canadensis) to highly pathogenic avian influenza virus (H5N1).

Authors:  John Pasick; Yohannes Berhane; Carissa Embury-Hyatt; John Copps; Helen Kehler; Katherine Handel; Shawn Babiuk; Kathleen Hooper-McGrevy; Yan Li; Quynh Mai Le; Song Lien Phuong
Journal:  Emerg Infect Dis       Date:  2007-12       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.